World News

T cell engagers are designed to bring a patient’s T cells into contact with cancer cells, enabling the immune cells to attack the tumour.

The companies said the partnership will support the introduction of MetMark into US laboratories using the XpressGT platform.

Under the proposal, timely pathogen sharing would support research and development while facilitating access to vaccines, medicines, diagnostics and other health products.

WHO bases its recommendations on surveillance data collected through the Global Influenza Surveillance and Response System (GISRS), supported by collaborating centres and essential regulatory laboratories.

ALMA and Malaria No More UK estimate that a 30% reduction in malaria financing could result in 146 million additional cases, almost 400,000 additional deaths and US$37 billion in lost economic output by 2030.

Earendil, a biotechnology company operating in the US and China, will identify and develop bispecific antibody programmes based on target combinations agreed with Genentech.

The collaboration comes as pharmaceutical developers explore alternative delivery routes for biologic medicines, which can present formulation and administration challenges because of their molecular size and complexity.

AIGP Health designed Anzu to help clinicians access relevant patient information and clinical context during consultations.

The meeting brought together leaders and partners from both regions to discuss how country led priorities, stronger regional capacity and predictable financing can strengthen health systems and improve preparedness for future health emergencies.

Lung adenocarcinoma is the most common form of lung cancer and can occur in both smokers and people who have never smoked.